Jump to content

Poniard Cancer Drug Fails Pivotal Study: BioBuzz


Recommended Posts

Poniard Cancer Drug Fails Pivotal Study: BioBuzz

SOUTH SAN FRANCISCO, Calif. (TheStreet) -- Poniard Pharmaceuticals'(PARD Quote) cancer drug picoplatin failed to significantly prolong survival in patients with advanced small cell lung cancer, according to results of a pivotal study disclosed Monday.

to read more: http://www.thestreet.com/story/10626994 ... obuzz.html

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.